Skip to main content
logo
Welcure Drugs and Pharmaceuticals Limited (BOM:524661)
India flag India · Delayed Price · Currency is INR
0.2400
0.00 (0.00%)
At close: Jul 28, 2026

BOM:524661 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
3,6553,655245.5--1.05
Revenue Growth
1388.95%1388.95%----21.26%
Gross Profit
431.71431.7140.45--1.05
Operating Income
-54.9-54.927.80.860.410.24
Net Income
-54.9-54.921.7-1.751.020.24
Earnings Per Share
-0.04-0.040.03-0.010.010.00
EPS Growth
----284.56%-57.25%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
5.765.761.280.220.010.66
Total Debt
--1,232---
Net Cash (Debt)
5.765.76-1,2310.220.010.66
Net Cash Growth
---1700.00%-98.18%39.09%
Net Cash Per Share
0.000.00-1.430.000.000.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
17.3517.35-2,220-1.281.070.19
Capital Expenditures
---0.17---
Free Cash Flow
17.3517.35-2,220-1.281.070.19
Free Cash Flow Growth
----476.20%-56.02%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
11.81%11.81%16.48%--100.00%
Operating Margin
-1.50%-1.50%11.32%--22.46%
Pretax Margin
-1.50%-1.50%11.32%--22.46%
Profit Margin
-1.50%-1.50%8.84%--22.46%
FCF Margin
0.47%0.47%-904.46%--17.67%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--47.13-53.41559.87
P/FCF Ratio
17.0917.09--50.81711.56
PS Ratio
0.080.084.17--125.73